Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Acquired Mutations in the Mitochondrial Genome As Prognostic Markers in Sickle Cell Disease

Rudra Ray, Haiou Li, Nancy Asomaning, Kang Le, Xunde Wang, Justin Lack, Yuesheng Li, Sayuri Kamimura, Zenaide Quezado, Swee Lay Thein

Blood (2024) 144 (Supplement 1): 2485.

https://doi.org/10.1182/blood-2024-203373

Published: 2024

Journal Articles

A Phase 1 Trial Evaluating the Addition of Lenalidomide to Relapsed/Refractory Multiple Myeloma Patients Progressing on Ruxolitinib and Methylprednisolone

James R Berenson, Andrea Limon, Stephanie Rice, Tahmineh Safaie, Ralph Boccia, Honghao Yang, Mehdi M. Moezi, Stephen Lim, Gary Schwartz, Shahrooz Eshaghian, Matthew Brobeck, Regina Swift, Benjamin M. Eades, Sean Bujarski, Yohana Sebhat, Rudra Ray, Susanna Kim, Robert Allen Vescio

Blood (2023) 142 (Supplement 1): 4753.

https://doi.org/10.1182/blood-2023-180287

Published: 2023

Journal Articles

Exploring Mitochondrial DNA Heteroplasmy in a Mouse Model of Sickle Cell Disease

Rudra Ray, John Hamre, Kang Le, Xunde Wang, Justin Lack, Yuesheng Li, Zenaide Quezado, Swee Lay Thein

Blood (2023) 142 (Supplement 1): 3858.

https://doi.org/10.1182/blood-2023-189660

Published: 2023

Journal Articles

Phenotypes of Hb Okayama Mutation

Rudra Ray, PhD MSc, Ankita Biswas, Msc, Sunistha Bhattacharjee, Msc, Maitreyee Bhattacharyya, DM

Blood (2018) 132 (Supplement 1): 4898.

https://doi.org/10.1182/blood-2018-99-118079

Published: 2018

Journal Articles

Decitabine As Hemoglobin F Inducer in Hemoglobin E/β Thalassemia

Siddhesh Arun Kalantri, MDMDcine, Rudra Ray, M.Sc, Arnab Chattopadhyay, MDPathology, Maitreyee Bhattacharyya, DM

Blood (2017) 130 (Supplement 1): 2224.

https://doi.org/10.1182/blood.V130.Suppl_1.2224.2224

Published: 2017

Journal Articles

Near Extinction of HbS Among the Tribes in Bengal: An Effect of Epistasis?

Rudra Ray, M.Sc, Swarnalata Roy, MBBS, Abira Sarkar, MBBS, Ranjini Chowdhury, M.Sc, Maitreyee Bhattacharyya, DM

Blood (2017) 130 (Supplement 1): 4777.

https://doi.org/10.1182/blood.V130.Suppl_1.4777.4777

Published: 2017

NARROW

Acquired Mutations in the Mitochondrial Genome As Prognostic Markers in Sickle Cell Disease

A Phase 1 Trial Evaluating the Addition of Lenalidomide to Relapsed/Refractory Multiple Myeloma Patients Progressing on Ruxolitinib and Methylprednisolone

Exploring Mitochondrial DNA Heteroplasmy in a Mouse Model of Sickle Cell Disease

Phenotypes of Hb Okayama Mutation

Decitabine As Hemoglobin F Inducer in Hemoglobin E/β Thalassemia

Near Extinction of HbS Among the Tribes in Bengal: An Effect of Epistasis?

Email alerts

ASH Publications

American Society of Hematology

Acquired Mutations in the Mitochondrial Genome As Prognostic Markers in Sickle Cell Disease

A Phase 1 Trial Evaluating the Addition of Lenalidomide to Relapsed/Refractory Multiple Myeloma Patients Progressing on Ruxolitinib and Methylprednisolone

Exploring Mitochondrial DNA Heteroplasmy in a Mouse Model of Sickle Cell Disease

Phenotypes of Hb Okayama Mutation

Decitabine As Hemoglobin F Inducer in Hemoglobin E/β Thalassemia

Near Extinction of HbS Among the Tribes in Bengal: An Effect of Epistasis?

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only